Healthcare Enterprise Group market a product called "Ebiox" which is one of a very few that can kill most bacteria including the MRSA superbug. HCEG has contracts with some NHS hospitals at present, but given the recent and current news and public attention, HCEG should be a good bet for a steady rise as more places seek to cut the number of casualties from this infection. HCEG also market abroad in USA, so the potential market for this unique product is massive indeed.

Well worth a punt IMHO

Check it out for yourself

How about calling the TV news channels !

10 Million buy has just gone through!

Bid/offer now 1.80p v 1.82p

Up she goes again. Offer now 1.85p

Spread now 1.82p v 1.85p. Nice!

mrsa still on the news - NHS where are you?

At last some movement on some big trades

Duty Rumour from elsewhere.(A.D.F.V.N.)

has stated that the NHS procurement area have indicated that ebiox and its range of products was being purchased in ever increasing quantities by hospitals throughout the country.

STRESS ONLY A RUMOUR

how true no idea,but nothing wrong with adding a fuel to the fire.

Today the government annouces new standards in cleaniness for the NHS one of the reasons MRSA is spread is lack of handwashing by doctors when going from patient to patient. Good timing for this product.



http://www.bma.org.uk/ap.nsf/Content/PR%2DBMA+welcomes+key+target+on+MRSA+%2D+21+Jul+2004

I also think that these disposable endoscopes they have produced is going to be a big winner.
http://u.tv/newsroom/indepth.asp?pt=n&id=47111

Morning all. Nice to see we are blue again.

I love blue

Nice 2.5 million delayed trade has just shown up.

There seems to be no shortage of buyers this morning. Would expect to see another tick up soon.

HCEFF is Healthcare Enterprise Group Inc., listed on the Nasdaq Over The Counter (OTC) market.

It was formed in February 2001 as a result of a collaboration between London & Paific Healthcare Development, Inc. (LPHD) and Moore Clayton & Co, Inc. (MCCI).

LPHD is a life sciences private equity and advisory firm founded in November 1998 by its principals, Stuart Bruck and Michael Low.

MCCI is a financial advisory firm specialising in the financial services, media and communications and energy industries and was founded in 1999.

HCEFF was used to takeover Interactivity Group Plc. (a shell company with a UK AIM listing) ... due to the respective sizes of the two companies it was viewed by the LSE as a reverse takeover i.e. after the deal Interactivity Plc. owned the entire issued share capital of HCEFF.

Interactivity Plc. then changed it's name to Healthcare Enterprise Group Plc. (HCEG.)

In a nutshell, HCEFF had obtained a UK (AIM) listing for it's business ... quicker and cheaper than floating the business themselves.

HCEG Plc. is currently the holding company of the HCEGI healthcare development business, which provides strategic advice and associated services primarily to early stage companies operating in the healthcare sector in return for fees which are payable in cash, equity or equity related securities.

I doubt you'll ever see any announcements from HCEFF ... all their stock (shares) are owned by HCEG Plc. so will not be traded on the Nasdaq OTC market.

I've no doubt that retaining a US listing is a good thing ... one day HCEG Plc. may want a US listing and they will be able to do it quickly and cheaply (again) using HCEFF.

Good to see buyers taking advantage of that dip.

Buying is picking up again

Has anyone been contacted by a broker called Edward Tate & Co. The firm is not registered with FSA. Beware!

Alert from FSA concerning this company at:

http://www.fsa.gov.uk/enforcement/edward_tate_24june04.pdf

A nice 2 million buy has just shown up.

AGM scheduled for 11.00am on monday 26/july